Dr. James (Jim) Brown has served as Novasenta’s Vice-President of Computational Sciences since May 2022. He has extensive biopharma industry experience leading computational biology support for pharmaceutical, vaccine and consumer health projects that span the drug development pipeline from early target discovery to clinical trials and launched products. Prior to Novasenta, Jim was Executive Director and Head of Computational Biology and Integrated Data Science at Kaleido Biosciences, a biotech focused on the discovery and clinical development of microbiome modulators for oncology and infectious, metabolic and inflammatory diseases. Jim’s industry experience began at GlaxoSmithKline (GSK) where he was employed for over 25 years rising to Scientific Director and Senior Fellow in Computational Biology. At GSK, he coordinated computational biology efforts across multiple drug discovery programs involving infectious diseases, host-pathogen interactions, the microbiome, oncology and metabolic, neurological, inflammatory and respiratory diseases.
Jim graduated with a B.Sc. Marine Biology from McGill University. He earned M.Sc. and Ph.D. degrees from Simon Fraser University. Jim received a Medical Research Council of Canada post-doctoral fellowship to work in the lab of Dr. W. Ford Doolittle, Dalhousie University on early cellular evolution. He has authored 118 publications and served on multiple academic and industrial advisory panels.